advertisement
Scheetz J 10
Showing records 1 to 10 | Display all abstracts from Scheetz J81430 A Randomized Trial to Increase the Assessment Accuracy of Glaucoma and Optic Disc Characteristics by Orthoptists
Scheetz J
The Journal of continuing education in the health professions 2019; 39: 161-167
80942 Real-world assessment of topical glaucoma medication persistence rates based on national pharmaceutical claim data in a defined population
Zhu Z; Jiang Y
Clinical and Experimental Ophthalmology 2019; 47: 881-891
81430 A Randomized Trial to Increase the Assessment Accuracy of Glaucoma and Optic Disc Characteristics by Orthoptists
Koklanis K
The Journal of continuing education in the health professions 2019; 39: 161-167
80942 Real-world assessment of topical glaucoma medication persistence rates based on national pharmaceutical claim data in a defined population
Wang W
Clinical and Experimental Ophthalmology 2019; 47: 881-891
81430 A Randomized Trial to Increase the Assessment Accuracy of Glaucoma and Optic Disc Characteristics by Orthoptists
McGuinness M
The Journal of continuing education in the health professions 2019; 39: 161-167
80942 Real-world assessment of topical glaucoma medication persistence rates based on national pharmaceutical claim data in a defined population
Scheetz J
Clinical and Experimental Ophthalmology 2019; 47: 881-891
81430 A Randomized Trial to Increase the Assessment Accuracy of Glaucoma and Optic Disc Characteristics by Orthoptists
Long M
The Journal of continuing education in the health professions 2019; 39: 161-167
80942 Real-world assessment of topical glaucoma medication persistence rates based on national pharmaceutical claim data in a defined population
Shang X
Clinical and Experimental Ophthalmology 2019; 47: 881-891
81430 A Randomized Trial to Increase the Assessment Accuracy of Glaucoma and Optic Disc Characteristics by Orthoptists
Morris ME
The Journal of continuing education in the health professions 2019; 39: 161-167
80942 Real-world assessment of topical glaucoma medication persistence rates based on national pharmaceutical claim data in a defined population
Zhang L; He M
Clinical and Experimental Ophthalmology 2019; 47: 881-891
